Pilulka Lekarny AS (XPRA:PINK) ROCE % : -153.28% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pilulka Lekarny AS's annualized ROCE % for the quarter that ended in Dec. 2023 was -153.28%.

Pilulka Lekarny AS ROCE % Historical Data

The historical data trend for Pilulka Lekarny AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pilulka Lekarny AS ROCE % Chart

Pilulka Lekarny AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-43.35

-12.91

-10.23

-28.70

-153.28

Pilulka Lekarny AS Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
ROCE %	Get a 7-Day Free Trial			-43.35	-12.91	-10.23	-28.70	-153.28

Pilulka Lekarny AS ROCE % Calculation

Pilulka Lekarny AS's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-165.39	/	( ( (605.963 - 433.642)	+	(439.7 - 396.223) )	/ 2 )
	=	-165.39	/	( (172.321	+	43.477)	/ 2 )
	=	-165.39	/	107.899
	=	-153.28 %

Pilulka Lekarny AS's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	-165.39	/	( ( (605.963 - 433.642)	+	(439.7 - 396.223) )	/ 2 )
	=	-165.39	/	( ( 172.321	+	43.477 )	/ 2 )
	=	-165.39	/	107.899
	=	-153.28 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

Pilulka Lekarny AS (XPRA:PINK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pilulka Lekarny AS ROCE % Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pilulka Lekarny AS (XPRA:PINK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Drahobejlova 1073/36, Prague, CZE, 190 00

Website

https://www.pilulka.cz

Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS (XPRA:PINK) Headlines

From GuruFocus

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor • 10-31-2022

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor • 02-02-2023